IMPURITIES AVAILABLE FOR 'Chidamide'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Chidamide. Chidamide is an oral histone deacetylase (HDAC) inhibitor that selectively targets HDAC subtypes 1, 2, 3, and 10. It modulates gene expression by increasing acetylation of histone proteins, leading to cell cycle arrest, apoptosis, and differentiation in cancer cells. Chidamide is primarily used in the treatment of peripheral T-cell lymphoma (PTCL) and other hematological malignancies. It can enhance anti-tumor immune responses by regulating immune-related genes. The drug is administered orally, usually in a cyclical dosing regimen. Common adverse effects include hematological toxicities, fatigue, gastrointestinal disturbances, and mild liver enzyme elevations. Chidamide has shown synergistic effects when combined with other anticancer therapies. It represents a targeted epigenetic therapy option in oncology. Buy high quality Chidamide from Omsynth Lifesciences.